BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1168 related articles for article (PubMed ID: 30714158)

  • 21. Heterogeneity in tumours: Validating the use of radiomic features on
    Krarup MMK; Nygård L; Vogelius IR; Andersen FL; Cook G; Goh V; Fischer BM
    Radiother Oncol; 2020 Mar; 144():72-78. PubMed ID: 31733491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of gray level discretization on radiomic feature stability for different CT scanners, tube currents and slice thicknesses: a comprehensive phantom study.
    Larue RTHM; van Timmeren JE; de Jong EEC; Feliciani G; Leijenaar RTH; Schreurs WMJ; Sosef MN; Raat FHPJ; van der Zande FHR; Das M; van Elmpt W; Lambin P
    Acta Oncol; 2017 Nov; 56(11):1544-1553. PubMed ID: 28885084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pretreatment
    Dissaux G; Visvikis D; Da-Ano R; Pradier O; Chajon E; Barillot I; Duvergé L; Masson I; Abgral R; Santiago Ribeiro MJ; Devillers A; Pallardy A; Fleury V; Mahé MA; De Crevoisier R; Hatt M; Schick U
    J Nucl Med; 2020 Jun; 61(6):814-820. PubMed ID: 31732678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Evaluation of Zero-Echo-Time Attenuation Correction for Brain 18F-FDG PET/MRI: Comparison with Atlas Attenuation Correction.
    Sekine T; Ter Voert EE; Warnock G; Buck A; Huellner M; Veit-Haibach P; Delso G
    J Nucl Med; 2016 Dec; 57(12):1927-1932. PubMed ID: 27339875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation of MR-Based Attenuation Correction of a Newly Released Whole-Body Simultaneous PET/MR System.
    Liu G; Cao T; Hu L; Zheng J; Pang L; Hu P; Gu Y; Shi H
    Biomed Res Int; 2019; 2019():8213215. PubMed ID: 31886254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of PET and CT radiomics for prediction of local tumor control in head and neck squamous cell carcinoma.
    Bogowicz M; Riesterer O; Stark LS; Studer G; Unkelbach J; Guckenberger M; Tanadini-Lang S
    Acta Oncol; 2017 Nov; 56(11):1531-1536. PubMed ID: 28820287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Tracer Uptake Time in Non-Small Cell Lung Cancer
    Kolinger GD; García DV; Kramer GM; Frings V; Zwezerijnen GJC; Smit EF; de Langen AJ; Buvat I; Boellaard R
    J Nucl Med; 2022 Jun; 63(6):919-924. PubMed ID: 34933890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A multi-modality physical phantom for mimicking tumor heterogeneity patterns in PET/CT and PET/MRI.
    Valladares A; Beyer T; Papp L; Salomon E; Rausch I
    Med Phys; 2022 Sep; 49(9):5819-5829. PubMed ID: 35838056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential feature exploration and model development based on 18F-FDG PET/CT images for differentiating benign and malignant lung lesions.
    Zhang R; Zhu L; Cai Z; Jiang W; Li J; Yang C; Yu C; Jiang B; Wang W; Xu W; Chai X; Zhang X; Tang Y
    Eur J Radiol; 2019 Dec; 121():108735. PubMed ID: 31733432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PET/MRI and PET/CT Radiomics in Primary Cervical Cancer: A Pilot Study on the Correlation of Pelvic PET, MRI, and CT Derived Image Features.
    Esfahani SA; Torrado-Carvajal A; Amorim BJ; Groshar D; Domachevsky L; Bernstine H; Stein D; Gervais D; Catalano OA
    Mol Imaging Biol; 2022 Feb; 24(1):60-69. PubMed ID: 34622425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Challenges and caveats of a multi-center retrospective radiomics study: an example of early treatment response assessment for NSCLC patients using FDG-PET/CT radiomics.
    van Timmeren JE; Carvalho S; Leijenaar RTH; Troost EGC; van Elmpt W; de Ruysscher D; Muratet JP; Denis F; Schimek-Jasch T; Nestle U; Jochems A; Woodruff HC; Oberije C; Lambin P
    PLoS One; 2019; 14(6):e0217536. PubMed ID: 31158263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repeatability of Radiomic Features in Non-Small-Cell Lung Cancer [(18)F]FDG-PET/CT Studies: Impact of Reconstruction and Delineation.
    van Velden FH; Kramer GM; Frings V; Nissen IA; Mulder ER; de Langen AJ; Hoekstra OS; Smit EF; Boellaard R
    Mol Imaging Biol; 2016 Oct; 18(5):788-95. PubMed ID: 26920355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
    Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
    Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Graph Neural Network Model for Prediction of Non-Small Cell Lung Cancer Lymph Node Metastasis Using Protein-Protein Interaction Network and
    Ju H; Kim K; Kim BI; Woo SK
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ability of FDG PET and CT radiomics features to differentiate between primary and metastatic lung lesions.
    Kirienko M; Cozzi L; Rossi A; Voulaz E; Antunovic L; Fogliata A; Chiti A; Sollini M
    Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1649-1660. PubMed ID: 29623375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [18F] FDG Positron Emission Tomography (PET) Tumor and Penumbra Imaging Features Predict Recurrence in Non-Small Cell Lung Cancer.
    Mattonen SA; Davidzon GA; Bakr S; Echegaray S; Leung ANC; Vasanawala M; Horng G; Napel S; Nair VS
    Tomography; 2019 Mar; 5(1):145-153. PubMed ID: 30854452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can integrated 18F-FDG PET/MR replace sentinel lymph node resection in malignant melanoma?
    Schaarschmidt BM; Grueneisen J; Stebner V; Klode J; Stoffels I; Umutlu L; Schadendorf D; Heusch P; Antoch G; Pöppel TD
    Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2093-2102. PubMed ID: 29876618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using CT texture analysis to differentiate between peripheral lung cancer and pulmonary inflammatory pseudotumor.
    Liu C; Ma C; Duan J; Qiu Q; Guo Y; Zhang Z; Yin Y
    BMC Med Imaging; 2020 Jul; 20(1):75. PubMed ID: 32631330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of texture features derived from static and respiratory-gated PET images in non-small cell lung cancer.
    Yip S; McCall K; Aristophanous M; Chen AB; Aerts HJ; Berbeco R
    PLoS One; 2014; 9(12):e115510. PubMed ID: 25517987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 59.